RESPOND TO PREVENT: Stepwise Pharmacy Naloxone Study

Clinical trial NCT03545321 · UNKNOWN

Trial details

NCT number: NCT03545321
Sponsor: Brandeis University
Status: UNKNOWN
Phase: Not Applicable
Study type: INTERVENTIONAL

Pharmacies Opioid Use Patient Safety

Start date: 2019-07-09
Primary completion: 2022-11-01
Enrollment: 450

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.